Related Experiment Video

Updated: Aug 30, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Treatment and prevention of pneumococcal pneumonia]

Paul Léophonte1, Julien Mazières

  • 1Service de pneumologie, hôpital Rangueil-Larrey, TSA 50032, 31059 Toulouse. leophonte.p@chu-toulouse.fr

La Revue Du Praticien
|October 16, 2003
PubMed

Insights

Community-acquired pneumonia caused by Streptococcus pneumoniae is common. High-dose amoxicillin is recommended despite some penicillin resistance, with vaccination advised for high-risk groups.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Context:

  • Streptococcus pneumoniae is a leading cause of community-acquired pneumonia (CAP).
  • 40% of S. pneumoniae strains in France show decreased penicillin susceptibility, with two-thirds being multidrug-resistant.
  • High-dose beta-lactams remain effective against most circulating strains.

Purpose:

  • To outline current treatment guidelines for S. pneumoniae CAP in France.
  • To discuss antibiotic resistance trends and their implications for treatment.
  • To highlight the role of pneumococcal vaccination in prevention.

Summary:

  • French guidelines recommend high-dose amoxicillin (3 g/day) as first-line CAP treatment due to in vivo effectiveness.
  • Telithromycin and ceftriaxone (1 g/day) are alternatives for severe cases or increasing resistance (MIC > 4 mg/L).
  • Pneumococcal vaccination is proven effective, especially in bacteremic pneumonia, and recommended for individuals with comorbidities and those aged 65+.

Impact:

  • Informs clinical practice regarding appropriate antibiotic selection for CAP.
  • Emphasizes the importance of monitoring antibiotic resistance patterns.
  • Promotes vaccination strategies to reduce the burden of pneumococcal pneumonia.

More Related Videos

Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...